Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr Jonathan Rich and Hem Pandya tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
BOSTON (BUSINESS WIRE) Anodyne Nanotech, Inc., a venture-backed biotechnology company based in Boston and specializing in the transdermal delivery of biologics, announced today the appointment of Jeff Mihm as a member of its Board of Directors.Mr. Mihm previously served as the CEO of Noven Pharmaceuticals, a leadi.
Backers included Velocity Partners, Relativity Healthcare Fund and Big Pi Ventures.
The company intends to use the funds to continue to develop its Hero Patch™ platform.
Founded by Hojat Rezaei Nejad, Konstantinos Tzortzakis, and Jake Lombardo, Anodyne Nanotech provides a Hero Patch™ platform, which uses microneedle technology to deliver clinically meaningful doses of macromolecules and small molecules.
By incorporating solvent-free bulk drug substance directly into microscopic porosities, Anodyne can load high amounts of the drug onto each microneedle. When the microneedle penetrates into the skin, the drug dissolves in the patient’s interstitial fluid and is systemically absorbed.
The company plans to conduct clinical trials to characterize the bioequivalence, safety and tolerability of several Hero Patch products.